nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—Costochondritis—Varenicline—nicotine dependence	0.0758	0.0894	CcSEcCtD
Propafenone—Cardiac flutter—Varenicline—nicotine dependence	0.0485	0.0571	CcSEcCtD
Propafenone—Gingival pain—Varenicline—nicotine dependence	0.0364	0.043	CcSEcCtD
Propafenone—Emotional disorder—Varenicline—nicotine dependence	0.0364	0.043	CcSEcCtD
Propafenone—Respiratory tract congestion—Varenicline—nicotine dependence	0.0218	0.0257	CcSEcCtD
Propafenone—Coronary artery disease—Varenicline—nicotine dependence	0.0201	0.0237	CcSEcCtD
Propafenone—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0162	0.0191	CcSEcCtD
Propafenone—Urine abnormality—Varenicline—nicotine dependence	0.0144	0.0169	CcSEcCtD
Propafenone—Urine analysis abnormal—Varenicline—nicotine dependence	0.0135	0.0159	CcSEcCtD
Propafenone—Platelet count decreased—Varenicline—nicotine dependence	0.0134	0.0158	CcSEcCtD
Propafenone—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0121	0.0143	CcSEcCtD
Propafenone—Intestinal obstruction—Varenicline—nicotine dependence	0.0117	0.0138	CcSEcCtD
Propafenone—Thrombosis—Varenicline—nicotine dependence	0.0112	0.0132	CcSEcCtD
Propafenone—Hyperlipidaemia—Varenicline—nicotine dependence	0.011	0.013	CcSEcCtD
Propafenone—Mania—Varenicline—nicotine dependence	0.0109	0.0129	CcSEcCtD
Propafenone—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00982	0.0696	CbGpPWpGaD
Propafenone—Glycosuria—Varenicline—nicotine dependence	0.00982	0.0116	CcSEcCtD
Propafenone—Eye irritation—Varenicline—nicotine dependence	0.00932	0.011	CcSEcCtD
Propafenone—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00881	0.0104	CcSEcCtD
Propafenone—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00881	0.0104	CcSEcCtD
Propafenone—Nocturia—Varenicline—nicotine dependence	0.00858	0.0101	CcSEcCtD
Propafenone—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00806	0.0571	CbGpPWpGaD
Propafenone—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00799	0.0566	CbGpPWpGaD
Propafenone—Blood pressure increased—Varenicline—nicotine dependence	0.00796	0.00938	CcSEcCtD
Propafenone—Abnormal dreams—Varenicline—nicotine dependence	0.00786	0.00927	CcSEcCtD
Propafenone—Eructation—Varenicline—nicotine dependence	0.00782	0.00921	CcSEcCtD
Propafenone—Nightmare—Varenicline—nicotine dependence	0.00768	0.00906	CcSEcCtD
Propafenone—Oesophagitis—Varenicline—nicotine dependence	0.00727	0.00857	CcSEcCtD
Propafenone—Mouth ulceration—Varenicline—nicotine dependence	0.00719	0.00848	CcSEcCtD
Propafenone—Hypertonia—Varenicline—nicotine dependence	0.00697	0.00822	CcSEcCtD
Propafenone—Lymphadenopathy—Varenicline—nicotine dependence	0.00677	0.00798	CcSEcCtD
Propafenone—Sleep disorder—Varenicline—nicotine dependence	0.00667	0.00786	CcSEcCtD
Propafenone—Diabetes mellitus—Varenicline—nicotine dependence	0.00664	0.00783	CcSEcCtD
Propafenone—Polyuria—Varenicline—nicotine dependence	0.00658	0.00775	CcSEcCtD
Propafenone—Deafness—Varenicline—nicotine dependence	0.00646	0.00761	CcSEcCtD
Propafenone—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00629	0.0446	CbGpPWpGaD
Propafenone—Libido decreased—Varenicline—nicotine dependence	0.00623	0.00734	CcSEcCtD
Propafenone—Hot flush—Varenicline—nicotine dependence	0.00617	0.00728	CcSEcCtD
Propafenone—Amnesia—Varenicline—nicotine dependence	0.00615	0.00725	CcSEcCtD
Propafenone—Menopausal symptoms—Varenicline—nicotine dependence	0.00612	0.00721	CcSEcCtD
Propafenone—Atrial fibrillation—Varenicline—nicotine dependence	0.00609	0.00718	CcSEcCtD
Propafenone—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00609	0.0431	CbGpPWpGaD
Propafenone—Arthritis—Varenicline—nicotine dependence	0.00594	0.007	CcSEcCtD
Propafenone—Cerebrovascular accident—Varenicline—nicotine dependence	0.00589	0.00695	CcSEcCtD
Propafenone—Osteoarthritis—Varenicline—nicotine dependence	0.00577	0.00681	CcSEcCtD
Propafenone—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00573	0.00675	CcSEcCtD
Propafenone—Psychotic disorder—Varenicline—nicotine dependence	0.00564	0.00665	CcSEcCtD
Propafenone—Urinary retention—Varenicline—nicotine dependence	0.00549	0.00647	CcSEcCtD
Propafenone—Liver function test abnormal—Varenicline—nicotine dependence	0.00533	0.00628	CcSEcCtD
Propafenone—Dry skin—Varenicline—nicotine dependence	0.00529	0.00624	CcSEcCtD
Propafenone—Dextropropoxyphene—OPRM1—nicotine dependence	0.00527	0.503	CrCbGaD
Propafenone—Hypokalaemia—Varenicline—nicotine dependence	0.00526	0.0062	CcSEcCtD
Propafenone—Breast disorder—Varenicline—nicotine dependence	0.00522	0.00615	CcSEcCtD
Propafenone—Fentanyl—OPRM1—nicotine dependence	0.00522	0.497	CrCbGaD
Propafenone—Cramp muscle—Varenicline—nicotine dependence	0.0052	0.00613	CcSEcCtD
Propafenone—Gastritis—Varenicline—nicotine dependence	0.00511	0.00602	CcSEcCtD
Propafenone—Abdominal distension—Varenicline—nicotine dependence	0.00502	0.00592	CcSEcCtD
Propafenone—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.005	0.0354	CbGpPWpGaD
Propafenone—Dysphagia—Varenicline—nicotine dependence	0.00499	0.00588	CcSEcCtD
Propafenone—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00496	0.0351	CbGpPWpGaD
Propafenone—Angina pectoris—Varenicline—nicotine dependence	0.00486	0.00573	CcSEcCtD
Propafenone—Pollakiuria—Varenicline—nicotine dependence	0.00461	0.00544	CcSEcCtD
Propafenone—Erectile dysfunction—Varenicline—nicotine dependence	0.0046	0.00542	CcSEcCtD
Propafenone—Weight increased—Varenicline—nicotine dependence	0.00454	0.00535	CcSEcCtD
Propafenone—Hyperglycaemia—Varenicline—nicotine dependence	0.0045	0.00531	CcSEcCtD
Propafenone—Infestation NOS—Varenicline—nicotine dependence	0.00445	0.00525	CcSEcCtD
Propafenone—Infestation—Varenicline—nicotine dependence	0.00445	0.00525	CcSEcCtD
Propafenone—Depression—Varenicline—nicotine dependence	0.00444	0.00523	CcSEcCtD
Propafenone—Stomatitis—Varenicline—nicotine dependence	0.00434	0.00511	CcSEcCtD
Propafenone—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00423	0.03	CbGpPWpGaD
Propafenone—Hepatobiliary disease—Varenicline—nicotine dependence	0.00421	0.00496	CcSEcCtD
Propafenone—Epistaxis—Varenicline—nicotine dependence	0.0042	0.00495	CcSEcCtD
Propafenone—Bradycardia—Varenicline—nicotine dependence	0.00407	0.00479	CcSEcCtD
Propafenone—Hypoaesthesia—Varenicline—nicotine dependence	0.00398	0.00469	CcSEcCtD
Propafenone—Urinary tract disorder—Varenicline—nicotine dependence	0.00395	0.00465	CcSEcCtD
Propafenone—Connective tissue disorder—Varenicline—nicotine dependence	0.00393	0.00463	CcSEcCtD
Propafenone—Urethral disorder—Varenicline—nicotine dependence	0.00392	0.00462	CcSEcCtD
Propafenone—Visual impairment—Varenicline—nicotine dependence	0.00385	0.00454	CcSEcCtD
Propafenone—Eye disorder—Varenicline—nicotine dependence	0.00373	0.0044	CcSEcCtD
Propafenone—Tinnitus—Varenicline—nicotine dependence	0.00372	0.00439	CcSEcCtD
Propafenone—Cardiac disorder—Varenicline—nicotine dependence	0.00371	0.00437	CcSEcCtD
Propafenone—Angiopathy—Varenicline—nicotine dependence	0.00362	0.00427	CcSEcCtD
Propafenone—Immune system disorder—Varenicline—nicotine dependence	0.00361	0.00425	CcSEcCtD
Propafenone—Mediastinal disorder—Varenicline—nicotine dependence	0.0036	0.00424	CcSEcCtD
Propafenone—Arrhythmia—Varenicline—nicotine dependence	0.00357	0.00421	CcSEcCtD
Propafenone—Mental disorder—Varenicline—nicotine dependence	0.0035	0.00413	CcSEcCtD
Propafenone—Erythema—Varenicline—nicotine dependence	0.00348	0.0041	CcSEcCtD
Propafenone—Malnutrition—Varenicline—nicotine dependence	0.00348	0.0041	CcSEcCtD
Propafenone—Flatulence—Varenicline—nicotine dependence	0.00343	0.00404	CcSEcCtD
Propafenone—Dysgeusia—Varenicline—nicotine dependence	0.00341	0.00401	CcSEcCtD
Propafenone—Muscle spasms—Varenicline—nicotine dependence	0.00334	0.00394	CcSEcCtD
Propafenone—Vision blurred—Varenicline—nicotine dependence	0.00328	0.00386	CcSEcCtD
Propafenone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00327	0.0231	CbGpPWpGaD
Propafenone—Tremor—Varenicline—nicotine dependence	0.00326	0.00384	CcSEcCtD
Propafenone—ADRB1—Monoamine GPCRs—DRD2—nicotine dependence	0.00323	0.0229	CbGpPWpGaD
Propafenone—Ill-defined disorder—Varenicline—nicotine dependence	0.00323	0.0038	CcSEcCtD
Propafenone—Anaemia—Varenicline—nicotine dependence	0.00321	0.00379	CcSEcCtD
Propafenone—Malaise—Varenicline—nicotine dependence	0.00314	0.0037	CcSEcCtD
Propafenone—Vertigo—Varenicline—nicotine dependence	0.00312	0.00368	CcSEcCtD
Propafenone—Syncope—Varenicline—nicotine dependence	0.00312	0.00368	CcSEcCtD
Propafenone—Palpitations—Varenicline—nicotine dependence	0.00307	0.00362	CcSEcCtD
Propafenone—Loss of consciousness—Varenicline—nicotine dependence	0.00306	0.0036	CcSEcCtD
Propafenone—Cough—Varenicline—nicotine dependence	0.00303	0.00358	CcSEcCtD
Propafenone—Convulsion—Varenicline—nicotine dependence	0.00301	0.00355	CcSEcCtD
Propafenone—Hypertension—Varenicline—nicotine dependence	0.003	0.00354	CcSEcCtD
Propafenone—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00298	0.0211	CbGpPWpGaD
Propafenone—Myalgia—Varenicline—nicotine dependence	0.00296	0.00349	CcSEcCtD
Propafenone—Chest pain—Varenicline—nicotine dependence	0.00296	0.00349	CcSEcCtD
Propafenone—Anxiety—Varenicline—nicotine dependence	0.00295	0.00348	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00294	0.00347	CcSEcCtD
Propafenone—Discomfort—Varenicline—nicotine dependence	0.00293	0.00345	CcSEcCtD
Propafenone—Dry mouth—Varenicline—nicotine dependence	0.0029	0.00341	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00288	0.0204	CbGpPWpGaD
Propafenone—Oedema—Varenicline—nicotine dependence	0.00284	0.00335	CcSEcCtD
Propafenone—Infection—Varenicline—nicotine dependence	0.00282	0.00332	CcSEcCtD
Propafenone—Shock—Varenicline—nicotine dependence	0.00279	0.00329	CcSEcCtD
Propafenone—Nervous system disorder—Varenicline—nicotine dependence	0.00278	0.00328	CcSEcCtD
Propafenone—Thrombocytopenia—Varenicline—nicotine dependence	0.00278	0.00328	CcSEcCtD
Propafenone—Tachycardia—Varenicline—nicotine dependence	0.00277	0.00327	CcSEcCtD
Propafenone—Skin disorder—Varenicline—nicotine dependence	0.00276	0.00325	CcSEcCtD
Propafenone—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.00276	0.0195	CbGpPWpGaD
Propafenone—Hyperhidrosis—Varenicline—nicotine dependence	0.00274	0.00323	CcSEcCtD
Propafenone—ADRB1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00272	0.0192	CbGpPWpGaD
Propafenone—Anorexia—Varenicline—nicotine dependence	0.00271	0.00319	CcSEcCtD
Propafenone—Hypotension—Varenicline—nicotine dependence	0.00265	0.00313	CcSEcCtD
Propafenone—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.00261	0.0185	CbGpPWpGaD
Propafenone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00259	0.00305	CcSEcCtD
Propafenone—Insomnia—Varenicline—nicotine dependence	0.00257	0.00303	CcSEcCtD
Propafenone—Dyspnoea—Varenicline—nicotine dependence	0.00253	0.00298	CcSEcCtD
Propafenone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00253	0.0179	CbGpPWpGaD
Propafenone—Somnolence—Varenicline—nicotine dependence	0.00252	0.00297	CcSEcCtD
Propafenone—Dyspepsia—Varenicline—nicotine dependence	0.0025	0.00295	CcSEcCtD
Propafenone—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0025	0.0177	CbGpPWpGaD
Propafenone—Decreased appetite—Varenicline—nicotine dependence	0.00247	0.00291	CcSEcCtD
Propafenone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00245	0.00289	CcSEcCtD
Propafenone—Fatigue—Varenicline—nicotine dependence	0.00245	0.00288	CcSEcCtD
Propafenone—Pain—Varenicline—nicotine dependence	0.00243	0.00286	CcSEcCtD
Propafenone—Constipation—Varenicline—nicotine dependence	0.00243	0.00286	CcSEcCtD
Propafenone—Feeling abnormal—Varenicline—nicotine dependence	0.00234	0.00276	CcSEcCtD
Propafenone—Gastrointestinal pain—Varenicline—nicotine dependence	0.00232	0.00274	CcSEcCtD
Propafenone—Urticaria—Varenicline—nicotine dependence	0.00225	0.00266	CcSEcCtD
Propafenone—Abdominal pain—Varenicline—nicotine dependence	0.00224	0.00264	CcSEcCtD
Propafenone—Body temperature increased—Varenicline—nicotine dependence	0.00224	0.00264	CcSEcCtD
Propafenone—Hypersensitivity—Varenicline—nicotine dependence	0.00209	0.00247	CcSEcCtD
Propafenone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00208	0.0147	CbGpPWpGaD
Propafenone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00206	0.0146	CbGpPWpGaD
Propafenone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00205	0.0145	CbGpPWpGaD
Propafenone—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00205	0.0145	CbGpPWpGaD
Propafenone—Asthenia—Varenicline—nicotine dependence	0.00204	0.0024	CcSEcCtD
Propafenone—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00203	0.0144	CbGpPWpGaD
Propafenone—Pruritus—Varenicline—nicotine dependence	0.00201	0.00237	CcSEcCtD
Propafenone—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00199	0.0141	CbGpPWpGaD
Propafenone—Diarrhoea—Varenicline—nicotine dependence	0.00194	0.00229	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00192	0.0136	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.00189	0.0134	CbGpPWpGaD
Propafenone—Dizziness—Varenicline—nicotine dependence	0.00188	0.00221	CcSEcCtD
Propafenone—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.00181	0.0128	CbGpPWpGaD
Propafenone—Vomiting—Varenicline—nicotine dependence	0.0018	0.00213	CcSEcCtD
Propafenone—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.0018	0.0128	CbGpPWpGaD
Propafenone—Rash—Varenicline—nicotine dependence	0.00179	0.00211	CcSEcCtD
Propafenone—Dermatitis—Varenicline—nicotine dependence	0.00179	0.00211	CcSEcCtD
Propafenone—Headache—Varenicline—nicotine dependence	0.00178	0.0021	CcSEcCtD
Propafenone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00176	0.0125	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00175	0.0124	CbGpPWpGaD
Propafenone—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00174	0.0123	CbGpPWpGaD
Propafenone—Nausea—Varenicline—nicotine dependence	0.00169	0.00199	CcSEcCtD
Propafenone—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.00168	0.0119	CbGpPWpGaD
Propafenone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00168	0.0119	CbGpPWpGaD
Propafenone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00167	0.0118	CbGpPWpGaD
Propafenone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00143	0.0101	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.00137	0.00972	CbGpPWpGaD
Propafenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00136	0.00961	CbGpPWpGaD
Propafenone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00134	0.00949	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00134	0.00946	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.00121	0.00856	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00116	0.00818	CbGpPWpGaD
Propafenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0011	0.00779	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.0011	0.00777	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00109	0.00771	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00107	0.00761	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000948	0.00672	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00094	0.00666	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000894	0.00633	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000886	0.00628	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000882	0.00624	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000874	0.00619	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000863	0.00611	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000803	0.00569	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000757	0.00536	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000755	0.00535	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000747	0.00529	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000739	0.00524	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000685	0.00485	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000624	0.00442	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00062	0.00439	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.000592	0.00419	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000584	0.00414	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000576	0.00408	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.000563	0.00399	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.000538	0.00381	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000535	0.00379	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	0.000407	0.00288	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	0.000405	0.00287	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000346	0.00245	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000318	0.00225	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGD1—nicotine dependence	0.000318	0.00225	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	0.000289	0.00205	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000281	0.00199	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	0.00023	0.00163	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	0.000209	0.00148	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—WASF2—nicotine dependence	0.000198	0.0014	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—WASF1—nicotine dependence	0.00019	0.00134	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000186	0.00132	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	0.000171	0.00121	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000162	0.00115	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000153	0.00108	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000152	0.00107	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000129	0.000917	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—DRD2—nicotine dependence	0.000123	0.000874	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	9.99e-05	0.000708	CbGpPWpGaD
